DarioHealth Corp.
DRIO
$11.94
-$0.03-0.25%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.29% | 41.79% | 47.21% | 32.87% | -2.09% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.29% | 41.79% | 47.21% | 32.87% | -2.09% |
| Cost of Revenue | -12.41% | -3.80% | -8.05% | -12.39% | -13.81% |
| Gross Profit | 19.93% | 79.04% | 100.26% | 76.44% | 7.27% |
| SG&A Expenses | -20.77% | -18.03% | -7.53% | 10.30% | 19.45% |
| Depreciation & Amortization | -42.68% | -14.48% | 6.09% | 14.64% | 7.50% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -23.37% | -17.02% | -4.90% | 10.00% | 11.65% |
| Operating Income | 35.12% | 34.71% | 21.04% | -1.70% | -18.00% |
| Income Before Tax | 14.60% | 16.53% | 19.88% | 24.87% | 14.57% |
| Income Tax Expenses | 109.11% | 108.50% | 108.50% | -2,993.75% | -64,866.67% |
| Earnings from Continuing Operations | 10.73% | 13.04% | 16.69% | 28.07% | 17.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10.73% | 13.04% | 16.69% | 28.07% | 17.93% |
| EBIT | 35.12% | 34.71% | 21.04% | -1.70% | -18.00% |
| EBITDA | 36.75% | 39.90% | 27.69% | 3.74% | -16.24% |
| EPS Basic | 37.39% | 42.19% | 64.61% | 66.21% | 53.94% |
| Normalized Basic EPS | 47.63% | 46.86% | 49.56% | 50.94% | 32.87% |
| EPS Diluted | 37.39% | 42.19% | 64.62% | 66.22% | 54.01% |
| Normalized Diluted EPS | 47.63% | 46.86% | 49.56% | 50.94% | 32.87% |
| Average Basic Shares Outstanding | 66.19% | 63.87% | 71.58% | 70.58% | 29.97% |
| Average Diluted Shares Outstanding | 66.19% | 63.87% | 71.58% | 70.58% | 29.97% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |